Product NDC: | 0037-7025 |
Proprietary Name: | Optivar |
Non Proprietary Name: | Azelastine Hydrochloride |
Active Ingredient(s): | .5 mg/mL & nbsp; Azelastine Hydrochloride |
Administration Route(s): | INTRAOCULAR |
Dosage Form(s): | SOLUTION/ DROPS |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0037-7025 |
Labeler Name: | Meda Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021127 |
Marketing Category: | NDA |
Start Marketing Date: | 20000522 |
Package NDC: | 0037-7025-60 |
Package Description: | 1 BOTTLE, PLASTIC in 1 BOX (0037-7025-60) > 6 mL in 1 BOTTLE, PLASTIC |
NDC Code | 0037-7025-60 |
Proprietary Name | Optivar |
Package Description | 1 BOTTLE, PLASTIC in 1 BOX (0037-7025-60) > 6 mL in 1 BOTTLE, PLASTIC |
Product NDC | 0037-7025 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Azelastine Hydrochloride |
Dosage Form Name | SOLUTION/ DROPS |
Route Name | INTRAOCULAR |
Start Marketing Date | 20000522 |
Marketing Category Name | NDA |
Labeler Name | Meda Pharmaceuticals Inc. |
Substance Name | AZELASTINE HYDROCHLORIDE |
Strength Number | .5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] |